Taiwan FDA registration 44dc1ffe9a0f1d7f934b7efc2045c664

Ampraz Aimulle left atrial appendage embolization device

TW: 安普拉茲艾幕勒左心耳栓塞裝置
Taiwan flagTaiwan·Risk Class 3·St. Jude Medical Costa Rica Ltda.;; Abbott Medical·Registered Feb 22, 2016 – Feb 22, 2026Expired
Registration details
Analysis ID
44dc1ffe9a0f1d7f934b7efc2045c664
Customs Code
DHA05602824203
Company information
Manufacturer Country
Costa Rica;;United States
Authorized Representative
Abbott Medical Taiwan Co.
Product details
Intended Use
For details, it is Chinese approved copy of the imitation order
Product Type (Level 1)
E Cardiovascular Medicine Science
Product Type (Level 2)
E.9999 Miscellaneous
Import Information
import
Dates and status
Registration Date
Feb 22, 2016
Expiry Date
Feb 22, 2026
Companies making similar products

Top companies providing products similar to "Ampraz Aimulle left atrial appendage embolization device"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Ampraz Aimulle left atrial appendage embolization device in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 44dc1ffe9a0f1d7f934b7efc2045c664 and manufactured by St. Jude Medical Costa Rica Ltda.;; Abbott Medical. The authorized representative in Taiwan is Abbott Medical Taiwan Co..

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Abbot Medical;; St. Jude Medical Costa Rica Ltda., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations